Word

KALEIDO

Status

Registered

Status Code

700

Status Date

Tuesday, December 17, 2019

Serial Number

86783357

Registration Number

5938245

Registration Date

Tuesday, December 17, 2019

Mark Type

4000

Filing Date

Friday, October 9, 2015

Published for Opposition

Tuesday, August 28, 2018

Trademark Owner History

KALEIDO BIOSCIENCES, INC. - Original Registrant
VL32, Inc. - Original Applicant

Classifications

5 preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis

Trademark Events

Dec 17, 2019

Registered-Principal Register

Nov 13, 2019

Notice Of Acceptance Of Statement Of Use E-Mailed

Nov 12, 2019

Allowed Principal Register - Sou Accepted

Nov 4, 2019

Statement Of Use Processing Complete

Oct 18, 2019

Use Amendment Filed

Nov 2, 2019

Case Assigned To Intent To Use Paralegal

Oct 18, 2019

Teas Statement Of Use Received

Apr 25, 2019

Notice Of Approval Of Extension Request E-Mailed

Apr 23, 2019

Extension 1 Granted

Apr 23, 2019

Extension 1 Filed

Apr 23, 2019

Teas Extension Received

Jan 2, 2019

Applicant/Correspondence Changes (Non-Responsive) Entered

Jan 2, 2019

Teas Change Of Owner Address Received

Oct 23, 2018

Noa E-Mailed - Sou Required From Applicant

Aug 28, 2018

Official Gazette Publication Confirmation E-Mailed

Aug 28, 2018

Published For Opposition

Aug 8, 2018

Notification Of Notice Of Publication E-Mailed

Jul 25, 2018

Exparte Appeal Terminated

Jul 25, 2018

Approved For Pub - Principal Register

Jul 24, 2018

Assigned To Examiner

Jul 24, 2018

Jurisdiction Restored To Examining Attorney

Sep 26, 2017

Notification Of Action Denying Req For Recon E-Mailed

Sep 26, 2017

Action Denying Req For Recon E-Mailed

Sep 26, 2017

Action Continuing Final - Completed

Sep 20, 2017

Teas/Email Correspondence Entered

Sep 20, 2017

Correspondence Received In Law Office

Sep 13, 2017

Assigned To Lie

Sep 6, 2017

Teas Request For Reconsideration Received

Sep 6, 2017

Ex Parte Appeal-Instituted

Sep 6, 2017

Jurisdiction Restored To Examining Attorney

Sep 6, 2017

Exparte Appeal Received At Ttab

Mar 8, 2017

Notification Of Final Refusal Emailed

Mar 8, 2017

Final Refusal E-Mailed

Mar 8, 2017

Final Refusal Written

Feb 22, 2017

Automatic Update Of Assignment Of Ownership

Feb 16, 2017

Teas/Email Correspondence Entered

Feb 16, 2017

Correspondence Received In Law Office

Feb 16, 2017

Teas Response To Office Action Received

Aug 24, 2016

Notification Of Non-Final Action E-Mailed

Aug 24, 2016

Non-Final Action E-Mailed

Aug 24, 2016

Non-Final Action Written

Aug 9, 2016

Teas/Email Correspondence Entered

Aug 8, 2016

Correspondence Received In Law Office

Aug 8, 2016

Teas Response To Office Action Received

Feb 8, 2016

Notification Of Non-Final Action E-Mailed

Feb 8, 2016

Non-Final Action E-Mailed

Feb 8, 2016

Non-Final Action Written

Feb 1, 2016

Assigned To Examiner

Oct 15, 2015

New Application Office Supplied Data Entered In Tram